Zobrazeno 1 - 10
of 47
pro vyhledávání: '"нежелательные реакции"'
Autor:
G. I. Syraeva, V. B. Vasilyuk, A. V. Verveda, M. V. Faraponova, A. S. Kolbin, V. G. Borovskaya
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 73-82 (2023)
Non-steroidal anti-inflammatory drugs are widely used by patients and medical workers, both in the Russian Federation and abroad. Despite the well-established public opinion about the safety of this group of drugs, their use is associated with toxic
Externí odkaz:
https://doaj.org/article/c797d8c511354299bee6ed341b27f170
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 12, Pp 28-32 (2023)
The objective: to evaluate comparative neurotoxicity of combinations of anti-tuberculosis and antimicrobial drugs with different and similar toxic potentials assessing behavioral changes in rats.Subjects and Methods: non-linear female rats divided in
Externí odkaz:
https://doaj.org/article/c9d2f4d2b034417a846b3feb7a32ca67
Autor:
A. L. Khokhlov, J. V. Rybachkova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 35-51 (2022)
Molnupiravir is an antiviral drug with a broad spectrum of activity against RNA viruses. The safety of molnupiravir in clinical trials with COVID-19 was analyzed. In a Phase I study (NCT04392219), molnupiravir was well tolerated at doses of 50 to 800
Externí odkaz:
https://doaj.org/article/9a10b9d3e57a4161b74cd9a6079def66
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 10, Pp 15-21 (2022)
The objective: to evaluate the variety of adverse reactions to combinations of clofazimine with anti-tuberculosis and antimicrobial drugs with different and similar toxic profiles.Subjects and Methods: Studies were carried on non-pedigree female rats
Externí odkaz:
https://doaj.org/article/feb12b977a1a45df8c9f1f4fa7b81461
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 9, Pp 6-10 (2022)
The objective: to identify factors influencing the development of dyspepsia in children during treatment with anti-tuberculosis drugs.Results: out of 243 children during chemotherapy, 22.6% developed dyspepsia as an adverse reaction. Risk factors sig
Externí odkaz:
https://doaj.org/article/da29cb79997941f8b7e0981db3525f6a
Autor:
O. D. Ostroumova, A. I. Listratov, A. I. Kochetkov, S. A. Bliznyuk, A. G. Komarova, D. A. Sychev
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 53-63 (2022)
Pulmonary arterial hypertension is a condition characterized by an increase in mean pressure in the pulmonary artery. This pathology is associated with high mortality, and specific therapy for pulmonary arterial hypertension does not affect the cause
Externí odkaz:
https://doaj.org/article/cea1a84208a14d13aa733a06bbeb54a5
Autor:
A. P. Pereverzev, O. D. Ostroumova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 53-59 (2022)
The use of many drugs is associated with the risk of adverse drug reactions (ADRs), including those that increase mortality and / or morbidity and / or seek medical help or hospitalization, so called «drug-induced diseases» (DID). There is a number
Externí odkaz:
https://doaj.org/article/c0c329a463ef4a1db804b172f9720e90
Autor:
A. P. Pereverzev, O. D. Ostroumova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 31-38 (2021)
Any drug is potentially associated with the risk of adverse drug reactions (ADRs), the incidence of which in developed and developing countries is estimated at 6.3 (3.3—11.0) and 5.5 % (1.1—16.9), respectively. Many ADRs increase mortality and /
Externí odkaz:
https://doaj.org/article/6714c7008718488c9564fca9a1ef6751
Autor:
D. A. Sychev, O. D. Ostroumova, A. P. Pereverzev, A. I. Kochetkov, T. M. Ostroumova, E. Yu. Ebzeeva, M. V. Klepikova
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 52-66 (2021)
Administration of a rational and safe drug therapy is one of the most challenging issues for healthcare professionals. The frequency of hospitalizations due to the adverse drug reactions in the years 2000 — 2015 was estimated at 6.3 (3.3—11.0 %)
Externí odkaz:
https://doaj.org/article/1d9f4ade3e084529a93d9d4cd60fb4fa
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 10, Pp 58-63 (2020)
The article presents the analysis of 36 publications about neurotoxic properties of anti-tuberculosis drugs, their clinical manifestations and mechanisms of the neurotoxic action. It specifies predisposing factors for the development of neurotoxicity
Externí odkaz:
https://doaj.org/article/19e0eb1237114138a3d83f3d86886f66